Evidence map›Paper›PMID 30952205›Full record

ArticleBMC systems biology2019

Identification of Hürthle cell cancers: solving a clinical challenge with genomic sequencing and a trio of machine learning algorithms.

Yangyang Hao, Quan-Yang Duh, Richard T Kloos, Joshua Babiarz, R Mack Harrell, S Thomas Traweek, Su Yeon Kim, Grazyna Fedorowicz, P Sean Walsh, Peter M Sadow and 2 more

Abstract read
In one paragraph

Article in BMC systems biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. A primer on machine learning techniques for genomic applications.Computational and structural biotechnology journal · 2021
    Review
  10. Article
  11. Features of Cytologically Indeterminate Molecularly Benign Nodules Treated With Surgery.The Journal of clinical endocrinology and metabolism · 2020
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yangyang HaoDepartment of Research & Development, Veracyte, Inc, 6000 Shoreline Court, Suite 300, South San Francisco, CA, 94080, USA.
Quan-Yang DuhDepartment of Surgery, Section of Endocrine Surgery, University of California San Francisco, San Francisco, CA, USA.
Richard T KloosDepartment of Medical Affairs, Veracyte, Inc, South San Francisco, USA.
Joshua BabiarzDepartment of Research & Development, Veracyte, Inc, 6000 Shoreline Court, Suite 300, South San Francisco, CA, 94080, USA.
R Mack HarrellThe Memorial Center for Integrative Endocrine Surgery, Hollywood, FL, USA.
S Thomas TraweekThyroid Cytopathology Partners, Austin, TX, USA.
Su Yeon KimDepartment of Research & Development, Veracyte, Inc, 6000 Shoreline Court, Suite 300, South San Francisco, CA, 94080, USA.
Grazyna FedorowiczDepartment of Research & Development, Veracyte, Inc, 6000 Shoreline Court, Suite 300, South San Francisco, CA, 94080, USA.
P Sean WalshDepartment of Research & Development, Veracyte, Inc, 6000 Shoreline Court, Suite 300, South San Francisco, CA, 94080, USA.
Peter M SadowDepartment of Pathology, Head and Neck Pathology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Jing HuangDepartment of Research & Development, Veracyte, Inc, 6000 Shoreline Court, Suite 300, South San Francisco, CA, 94080, USA.
Giulia C KennedyDepartment of Research & Development, Veracyte, Inc, 6000 Shoreline Court, Suite 300, South San Francisco, CA, 94080, USA. giulia@veracyte.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentification of Hürthle cell cancers by non-operative fine-needle aspiration biopsy (FNAB) of thyroid nodules is challenging. Resultingly, non-cancerous Hürthle lesions were conventionally distinguished from Hürthle cell cancers by histopathological examination of tissue following surgical resection. Reliance on histopathological evaluation requires patients to undergo surgery to obtain a diagnosis despite most being non-cancerous. It is highly desirable to avoid surgery and to provide accurate classification of benignity versus malignancy from FNAB preoperatively. In our first-generation algorithm, Gene Expression Classifier (GEC), we achieved this goal by using machine learning (ML) on gene expression features. The classifier is sensitive, but not specific due in part to the presence of non-neoplastic benign Hürthle cells in many FNAB.

resultsWe sought to overcome this low-specificity limitation by expanding the feature set for ML using next-generation whole transcriptome RNA sequencing and called the improved algorithm the Genomic Sequencing Classifier (GSC). The Hürthle identification leverages mitochondrial expression and we developed novel feature extraction mechanisms to measure chromosomal and genomic level loss-of-heterozygosity (LOH) for the algorithm. Additionally, we developed a multi-layered system of cascading classifiers to sequentially triage Hürthle cell-containing FNAB, including: 1. presence of Hürthle cells, 2. presence of neoplastic Hürthle cells, and 3. presence of benign Hürthle cells. The final Hürthle cell Index utilizes 1048 nuclear and mitochondrial genes; and Hürthle cell Neoplasm Index leverages LOH features as well as 2041 genes. Both indices are Support Vector Machine (SVM) based. The third classifier, the GSC Benign/Suspicious classifier, utilizes 1115 core genes and is an ensemble classifier incorporating 12 individual models.

conclusionsThe accurate algorithmic depiction of this complex biological system among Hürthle subtypes results in a dramatic improvement of classification performance; specificity among Hürthle cell neoplasms increases from 11.8% with the GEC to 58.8% with the GSC, while maintaining the same sensitivity of 89%.

Indexed as

Machine LearningSequence AnalysisGene Expression ProfilingGenomicsHeterozygoteHumansMitochondriaNeoplasmsOxyphil CellsAlgorithmGenomicHürthleMachine learningPersonalized healthcareRNA-seqThyroid cancer

Identifiers

PMID30952205
PMCPMC6450053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.